Beruflich Dokumente
Kultur Dokumente
1
Objectives
2
Outbreaks Linked to Unsafe
Injection Practices
• In the last 10 years, 33 infectious disease
outbreaks, such as Hepatitis C, have been
reported; thousands of patients have been
notified that they may have been harmed
• Referral of providers to licensing boards for
disciplinary action
• Legal actions such as malpractice suits
filed by patients
• Nearly half of the outbreaks were
related to anesthesia/sedation
3
Viral Hepatitis Outbreaks in Outpatient
Settings Due to Unsafe Injection Practices
State Setting Year Type
2001 to 2010
NY Private MD office 2001 HCV
n=16
NY Private MD office 2001 HBV
NE Oncology clinic 2002 HCV
OK Pain remediation clinic 2002 HBV+HCV
NY Endoscopy clinic 2002 HCV
CA Pain remediation clinic (ASC) 2003 HCV
MD Nuclear imaging 2004 HCV
FL Chelation therapy 2005 HBV
CA Alternative medicine clinic 2005 HCV
NY Endoscopy/surgery clinics 2006 HBV+HCV
NY Anesthesiologist / pain clinic 2007 HCV
4
Nevada Hepatitis C Outbreak
• January 2008: cluster of three acute Hepatitis C virus
(HCV) cases identified in Las Vegas
• All three patients underwent procedures at the same
endoscopy clinic during the incubation period
• Clinic performed upper and lower endoscopies
• 50-60 procedures/day
• 2 procedure rooms
• Reviews of surveillance records, laboratory records and a
physician report identified three additional clinic-
associated cases; health department later identified over
77 additional HCV cases likely acquired at the clinic
(MMWR: May 16, 2008; 57:19)
5
Review of Anesthesia Delivery
• Started induction with syringe filled with lidocaine (1 cc)
and propofol (9 ccs)
• Clean needle and syringe used to inject directly through
intravenous catheter
• If patient need more anesthesia, some providers:
• Removed needle from syringe and replaced with a new one
• Used old syringe w/ new needle to draw more propofol
• Medication remaining in the single dose propofol vial was
used to sedate the next patient
6
Review of Anesthesia Delivery
• Propofol is a single-dose
medication
• Preservative free
• Approved for use on a single
patient for a single procedure
• Facility purchased 20-50 cc vials
but only used approximately 10-15 cc
per patient
7
Unsafe Injection Practices That
Likely Lead to HCV Transmission
8
Bacterial Outbreaks due to Unsafe
Injection Practices
Pain clinic: seven cases of Serratia marcescens
• Spinal injections; all patients hospitalized
9
Safe Injection Practice Research
10
Incorrect Practices That Have Resulted
in Transmission of Pathogens
• Direct (i.e., “overt”) syringe reuse
• Using the same syringe from patient to patient
(with/without the same needle)
• Indirect syringe reuse
• Accessing shared multi-dose medication vials or bags
with a used syringe that will be used on subsequent
patients (with/without the same needle)
• Reuse of single dose vials
• Diversion
11
Provider-to-Patient Transmission of HCV
Associated with Diversion of Fentanyl
Colorado, 2009
• HCV-infected surgery technician stole fentanyl
syringes that had been pre-drawn and left
unattended in the ORs
• Contaminated syringes were refilled with saline
and swapped with unused syringes
• 24 patients infected; nearly 600 notified
• Diversion has emerged as the leading cause of
provider to patient HCV transmission
12
Injection Practice Myths
14
Single-use Medication Reuse
15
Multi-dose Vials
16
Inappropriate Handling of
Multi-dose Medications
17
Appropriate Handling of
Multi-dose Medications
Multi-dose medication should be:
• Dedicated to single patient, whenever possible
• Entered only with sterile needle and sterile syringe
• Rubber septum should be disinfected with alcohol prior to
each entry
• Dated upon initial entry and discarded within 28 days of
opening or according to manufacturer’s instructions
• Discarded if sterility is compromised
Multi-dose medications should not be:
• Kept in the immediate patient treatment area
18
Expiration Date Versus
Beyond-use Date
Manufacturer’s expiration date: the date after
which an unopened multi-dose vial should not be
used
19
Spiking/Priming IV Bags
“In Advance”
United States Pharmacopeial Convention (USP):
1 hour time limit from preparation (spiking bag)
until beginning administration if not prepared in
an ISO 5 environment
• Precludes microbial growth in the event of
contamination
• Organisms replication can occur within 1-4 hours
20
Medication Labeling
21
Re-education is KEY
• Individuals want to do the right thing, which might include
not wasting medications that are expensive or in short
supply
• Individual training may be inadequate or incorrect
• There may be a lack of understanding of how bloodborne
pathogens are transmitted
• Culture at the work place may not support individuals
speaking up when they see non-compliance
• Cost and supply can be barriers to changing to single-dose
medication distribution systems
22
CDC Injection Safety Campaign
23
Oregon Survey Findings
24
Important
25
Tip: A Special Note on Code Carts
26
Toolkit Contents
27
Infections Associated with Unsafe
Diabetes Care Practices
28
Hepatitis B Virus Outbreaks
29
Device-associated HBV Transmission
Among Persons with Diabetes
30
Lancet and Insulin Syringes
31
Multi-dose Insulin Pens
32
Fingerstick Devices
Recommendations
• Fingerstick devices should never be used
for more than one person
• Autodisabling single-use fingerstick devices
should be used for assisted monitoring of
blood glucose
33
Blood Glucose Meters
34
Insulin Pens and Vials
35
Gloves
36
Storage
37
Additional Focus
38
Toolkit Contents
39
Conclusions
40